Covaxin’s WHO approval set back again. Here’s what we know

Covaxin's approval is facing multiple delays despite the pharmaceutical company’s claims that they’ve submitted all data necessary.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Y7VOGD
via IFTTT